{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "30046982",
  "DateCompleted": {
    "Year": "2019",
    "Month": "06",
    "Day": "20"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "06",
    "Day": "20"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1007/82_2018_108"
    ],
    "Journal": {
      "ISSN": "0070-217X",
      "JournalIssue": {
        "Volume": "416",
        "PubDate": {
          "Year": "2018"
        }
      },
      "Title": "Current topics in microbiology and immunology",
      "ISOAbbreviation": "Curr Top Microbiol Immunol"
    },
    "ArticleTitle": "Extraintestinal Pathogenic Escherichia coli.",
    "Pagination": {
      "StartPage": "149",
      "EndPage": "161",
      "MedlinePgn": "149-161"
    },
    "Abstract": {
      "AbstractText": [
        "Extraintestinal pathogenic E. coli (ExPEC) present a major clinical problem that has emerged in the past years. Most of the infections are hospital or community-acquired and involve patients with a compromised immune system. The infective agents belong to a large number of strains of different serotypes that do not cross react. The seriousness of the infection is due to the fact that most of the infecting bacteria are highly antibiotic resistant. Here, we discuss the bacterial factors responsible for pathogenesis and potential means to combat the infections."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Molecular Microbiology and Biotechnology, Faculty of Life Sciences, Tel Aviv University, 39978, Tel Aviv, Israel."
          }
        ],
        "LastName": "Biran",
        "ForeName": "Dvora",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Molecular Microbiology and Biotechnology, Faculty of Life Sciences, Tel Aviv University, 39978, Tel Aviv, Israel. eliora@post.tau.ac.il."
          }
        ],
        "LastName": "Ron",
        "ForeName": "Eliora Z",
        "Initials": "EZ"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Germany",
    "MedlineTA": "Curr Top Microbiol Immunol",
    "NlmUniqueID": "0110513",
    "ISSNLinking": "0070-217X"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Bacterial Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Escherichia coli Proteins"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "pharmacology",
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Bacterial Agents"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Drug Resistance, Microbial"
    },
    {
      "QualifierName": [
        "drug therapy",
        "immunology",
        "microbiology"
      ],
      "DescriptorName": "Escherichia coli Infections"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Escherichia coli Proteins"
    },
    {
      "QualifierName": [
        "drug effects",
        "immunology",
        "pathogenicity"
      ],
      "DescriptorName": "Extraintestinal Pathogenic Escherichia coli"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    }
  ]
}